
Stryker (SYK) Stock Forecast & Price Target
Stryker (SYK) Analyst Ratings
Bulls say
Stryker's management has reiterated expectations for a significant increase in operating margin by approximately 100 basis points by 2025, indicating potential for continued profitability amidst challenges such as tariffs. The company has reported remarkable growth in its order book and demonstrated strong performance with record MAKO installations, underscoring healthy momentum in its orthopedic division. Additionally, Stryker's strategic focus on high-growth markets has led to an increase in its weighted average market growth rate, positioning the company for robust revenue and earnings per share growth in the coming years.
Bears say
Stryker's outlook is negatively impacted by several challenges, including disruptions from recent acquisitions, a deceleration in Mako utilization due to increased competition, and a weaker capital environment for hospitals. Organic revenue growth is anticipated to slow to 8% or less, compounded by potential earnings dilution from acquisitions and underwhelming new product launches, which may lead to below-consensus earnings projections. Furthermore, risks such as reduced market growth in orthopedics, challenges in capital spending, and integration difficulties from acquisitions contribute to a forecast of limited margin expansion and overall earnings growth.
This aggregate rating is based on analysts' research of Stryker and is not a guaranteed prediction by Public.com or investment advice.
Stryker (SYK) Analyst Forecast & Price Prediction
Start investing in Stryker (SYK)
Order type
Buy in
Order amount
Est. shares
0 shares